MET and neoplasm: In this study, glycovariants of stemness-related biomarker candidates OCT4, MET, CIP2A and LIMA1 were screened from two HNSCC cell lines and, further, from a panel of 25 HNSCC patients using samples of tumor tissue, adjacent normal tissue, and serum samples (Supplemental Fig. 1).